High Hopes and Dilemmas for a Cervical Cancer Vaccine

+ See all authors and affiliations

Science  29 Apr 2005:
Vol. 308, Issue 5722, pp. 618-621
DOI: 10.1126/science.308.5722.618

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


As two vaccines against a sexually transmitted virus approach the market, public health experts are debating who should receive them--women, boys, or girls--and how to make them affordable in developing countries where the need is highest.

Related Content